Captrust Financial Advisors Edwards Lifesciences Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 44,455 shares of EW stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,455

Previous 49,484 10.16%

Holding current value

$3.09 Million

Previous $4.57 Million 35.82%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $300,231 - $471,619	-5,029 Reduced 10.16%	44,455 $2.93 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $179,559 - $200,880	-2,130 Reduced 4.13%	49,484 $4.57 Million
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $678,611 - $893,963	-9,355 Reduced 15.34%	51,614 $4.93 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $311,512 - $392,532	-5,048 Reduced 7.65%	60,969 $4.65 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.11 Million - $1.5 Million	16,068 Added 32.17%	66,017 $4.57 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $285,993 - $331,381	-3,513 Reduced 6.57%	49,949 $4.71 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $163,594 - $186,175	2,203 Added 4.3%	53,462 $4.42 Million
Q4 2022 Feb 15, 2023	BUY	$68.3 - $87.44 $90,360 - $115,683	1,323 Added 2.65%	51,259 $3.82 Million
Q3 2022 Nov 16, 2022	BUY	$82.37 - $107.29 $900,304 - $1.17 Million	10,930 Added 28.02%	49,936 $4.13 Million
Q2 2022 Aug 23, 2022	SELL	$86.5 - $128.27 $703,850 - $1.04 Million	-8,137 Reduced 17.26%	39,006 $3.71 Million
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $641,743 - $951,635	7,419 Added 18.68%	47,143 $4.48 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $1.54 Million - $1.94 Million	15,141 Added 61.59%	39,724 $4.68 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $503,449 - $618,508	4,733 Added 23.84%	24,583 $3.19 Million
Q3 2021 Nov 16, 2021	SELL	$102.91 - $122.75 $5,454 - $6,505	-53 Reduced 0.27%	19,850 $2.25 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $1.06 Million - $1.32 Million	-12,629 Reduced 38.82%	19,903 $2.06 Million
Q1 2021 May 17, 2021	SELL	$78.68 - $90.67 $1.55 Million - $1.79 Million	-19,706 Reduced 37.72%	32,532 $2.72 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $1.06 Million - $1.35 Million	14,840 Added 39.68%	52,238 $4.77 Million
Q3 2020 Nov 17, 2020	SELL	$67.19 - $87.44 $23.7 Million - $30.9 Million	-352,919 Reduced 90.42%	37,398 $2.95 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $15 Million - $20 Million	259,947 Added 199.39%	390,317 $26.9 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $4.42 Million - $6.82 Million	-84,244 Reduced 39.25%	130,370 $22.5 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $15.3 Million - $17.5 Million	213,669 Added 22610.48%	214,614 $49.9 Million
Q3 2019 Nov 14, 2019	SELL	$61.55 - $75.43 $1,169 - $1,433	-19 Reduced 1.97%	945 $208,000
Q2 2019 Aug 13, 2019	BUY	$55.74 - $64.41 $3,678 - $4,251	66 Added 7.35%	964 $178,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $8,524 - $11,400	178 Added 24.72%	898 $172,000
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $19,492 - $23,914	-420 Reduced 36.84%	720 $110,000
Q3 2018 Nov 15, 2018	SELL	$45.7 - $58.03 $19,194 - $24,372	-420 Reduced 26.92%	1,140 $198,000
Q2 2018 Aug 13, 2018	SELL	$42.45 - $51.3 $24,705 - $29,856	-582 Reduced 27.17%	1,560 $227,000
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $12,347 - $15,753	332 Added 18.34%	2,142 $290,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $61,159 - $71,295	1,810	1,810 $204,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Edwards Lifesciences Corp Transaction History